Explore

Reuters Reuters
US court blocks mail-order access to abortion drugs, for now

US court blocks mail-order access to abortion drugs, for now

By Daniel Wiessner May 1 (Reuters) - A U.S. appeals court on Friday temporarily blocked a federal rule allowing the abortion drug mifepristone to be dispensed through the mail, significantly curtailing access to the drug nationwide and particularly in states that have banned abortion. 
Reuters Reuters
Abortion pill makers ask US Supreme Court to restore mail-order access

Abortion pill makers ask US Supreme Court to restore mail-order access

By Ismail Shakil May 2 (Reuters) - Two drugmakers have asked the U.S. Supreme Court to restore mail-order access to mifepristone, a move that would continue to allow women access to one of the most widely used abortion methods pending ongoing legal challenges.
AP News AP News
Court restricts abortion access across the US by blocking the mailing of mifepristone

Court restricts abortion access across the US by blocking the mailing of mifepristone

A federal appeals court has restricted access to one of the most common means of abortion in the U.S. by blocking the mailing of mifepristone
Rapid Read Rapid Read
Supreme Court Asked to Maintain Mail Access for Abortion Drug Mifepristone

Supreme Court Asked to Maintain Mail Access for Abortion Drug Mifepristone

Danco Laboratories and GenBioPro have filed an emergency appeal to the Supreme Court, seeking to pause a lower court ruling that restricts mail-order access to the abortion drug mifepristone. The 5th U.S. Circuit Court of Appeals recently reinstated a requirement for in-person prescriptions, challenging the Biden administration's previous rule change that allowed mail distribution. Louisiana's lawsuit against the FDA argues that mail delivery of mifepristone facilitates illegal abortions and circumvents state bans. The appeals court's decision has prompted concerns about confusion and disruption in medical decision-making.
Rapid Read Rapid Read
Federal Appeals Court Blocks Mail Access to Mifepristone, Impacting Abortion Access

Federal Appeals Court Blocks Mail Access to Mifepristone, Impacting Abortion Access

A federal appeals court has issued a ruling that prevents the distribution of mifepristone abortion pills through the mail, a decision expected to significantly restrict abortion access in states where it is banned. The U.S. 5th Circuit Court of Appeals in New Orleans responded to a lawsuit from Louisiana, which challenged federal regulations allowing the mailing of mifepristone. Louisiana Attorney General Liz Murrill argued that the regulation led to illegal abortions and increased Medicaid costs. The court's decision blocks the FDA rule permitting mail distribution, citing that it undermines Louisiana's laws and increases Medicaid expenses due to emergency care for complications. The ruling is anticipated to be appealed to the Supreme Court.
Rapid Read Rapid Read
Federal Court Blocks Mailing of Mifepristone, Restricting Abortion Access

Federal Court Blocks Mailing of Mifepristone, Restricting Abortion Access

A federal appeals court has ruled to block the mailing of mifepristone, a common abortion pill, requiring it to be distributed only in person at clinics. This decision by the 5th U.S. Circuit Court of Appeals challenges FDA regulations and is expected to be appealed to the Supreme Court. The ruling is a significant development in U.S. abortion policy following the 2022 Supreme Court decision that overturned Roe v. Wade. The court's decision aligns with Louisiana's stance against abortion, emphasizing the state's policy that every unborn child is a legal person from conception.
Rapid Read Rapid Read
Federal Appeals Court Restricts Mail-Order Access to Abortion Pill Mifepristone

Federal Appeals Court Restricts Mail-Order Access to Abortion Pill Mifepristone

A federal appeals court has issued a ruling that restricts the distribution of the abortion pill mifepristone by mail, mandating that it be dispensed only in person at clinics. This decision by the 5th U.S. Circuit Court of Appeals comes as a significant development in the ongoing legal battles over abortion access in the United States. The ruling challenges the FDA's regulations that previously allowed the pill to be prescribed via telehealth and mailed to patients, a practice that became more common during the COVID-19 pandemic. The court's decision is seen as a victory for abortion opponents who argue that mail-order access undermines state bans on abortion. The case is expected to be appealed to the Supreme Court, as Danco Laboratories, the manufacturer of mifepristone, has requested a stay on the ruling while appeals are pending.
Rapid Read Rapid Read
Supreme Court Asked to Maintain Mail Access for Abortion Drug Mifepristone Amid Legal Challenges

Supreme Court Asked to Maintain Mail Access for Abortion Drug Mifepristone Amid Legal Challenges

The Supreme Court is being petitioned to keep the abortion drug mifepristone available by mail following a lower court's decision to block its distribution. This request comes after the 5th U.S. Circuit Court of Appeals temporarily reinstated a requirement for in-person prescriptions, a rule previously eliminated by the Biden administration. Louisiana, supported by several Republican-led states, argues that mailing the drug facilitates nearly 1,000 illegal abortions monthly and poses health risks such as sepsis and hemorrhaging. Danco Laboratories, a manufacturer of mifepristone, has filed an emergency appeal, claiming the ruling causes confusion and disrupts medical decisions. The case highlights ongoing legal battles over abortion access in the U.S., with the Supreme Court's decision potentially impacting the availability of mifepristone nationwide.
Reuters Reuters
Danco seeks Supreme Court stay of ruling that pauses mail-order access to abortion drugs

Danco seeks Supreme Court stay of ruling that pauses mail-order access to abortion drugs

By Ismail Shakil May 2 (Reuters) - Pharmaceutical company Danco Laboratories filed an application with the U.S. Supreme Court on Saturday seeking a stay of an appeals court ruling that temporarily blocks the abortion drug mifepristone from being dispensed through the mail.
Rapid Read Rapid Read
Federal Court Blocks Mailing of Abortion Pill Mifepristone, Affecting Nationwide Access

Federal Court Blocks Mailing of Abortion Pill Mifepristone, Affecting Nationwide Access

A federal appeals court has ruled to restrict the distribution of the abortion pill mifepristone, mandating that it can only be dispensed in person at clinics. This decision by the 5th U.S. Circuit Court of Appeals in New Orleans challenges the previous allowance for the pill to be mailed, a method that became prevalent following the Supreme Court's 2022 decision overturning Roe v. Wade. The ruling aligns with Louisiana's stance that every unborn child is a legal person from conception. The decision is expected to significantly impact access to abortion, particularly in states with strict abortion bans.
Rapid Read Rapid Read
Federal Appeals Court Halts Mail Delivery of Abortion Pills to Texans Amid Legal Challenge

Federal Appeals Court Halts Mail Delivery of Abortion Pills to Texans Amid Legal Challenge

A federal appeals court has issued a temporary block on the mail delivery of abortion medication to residents of Texas. The 5th U.S. Circuit Court of Appeals made this decision as part of an ongoing lawsuit initiated by the state of Louisiana. The lawsuit challenges federal rules that currently permit the mailing of abortion pills, such as mifepristone, to states where abortion is banned, including Texas. This legal action reflects ongoing disputes over abortion access following changes in state laws and federal regulations.
Rapid Read Rapid Read
Federal Court Halts Mail Delivery of Abortion Pills to Texans Amid Legal Challenge

Federal Court Halts Mail Delivery of Abortion Pills to Texans Amid Legal Challenge

A federal appeals court has temporarily blocked the mail delivery of abortion medication to Texas residents. The 5th U.S. Circuit Court of Appeals issued the order while a lawsuit from Louisiana is underway. The lawsuit challenges federal rules that allow abortion pills, such as mifepristone, to be mailed to states with abortion bans, including Texas. This legal action is part of ongoing disputes over abortion access following changes in federal and state laws.